EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

APOE genotype, eicosapentaenoic acid (EPA) supplementation and n-3 highly unsaturated fatty acid (HUFA) levels in patients with multiple colorectal polyps: A secondary analysis of the seAFOod polyp prevention trial

Ge Sun, John R Davies, Tracey Mell, Mark Harland, Rasha M H Saleh, Amanda D Race, Paul M Loadman, Elizabeth A Williams, Anne Marie Minihane, Mark A Hull

Prostaglandins, Leukotrienes and Essential Fatty Acids · 2024

DOI: 10.1016/j.plefa.2024.102623 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Prostaglandins, Leukotrienes and Essential Fatty Acids, 2024. Verfasst von Ge Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Institute of Medical Research, University of Leeds, UK. Hauptthemen laut MEDLINE: Eicosapentaenoic Acid, Dietary Supplements, Fatty Acids, Omega-3, Apolipoproteins E. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Medical Research Council, National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: We examined the relationship between Apolipoprotein E (APOE) genotype and n-3 highly unsaturated fatty acid (HUFA) levels in participants of the seAFOod trial, who were undergoing colonoscopy surveillance after removal of colorectal polyps. METHODS: Baseline and on-treatment (eicosapentaenoic acid [EPA] 2 g daily or placebo for 6 months) levels of n-3 HUFAs, and plasma 18-hydroxyeicosapentaenoic acid (HEPE), were analysed according to APOE genotype (based on polymorphisms rs429358 and rs7412) in 584 participants. RESULTS: Before treatment, APOE2/2 individuals had lower levels, and APOE4/4 participants had higher levels, of n-3 HUFAs, including EPA, than APOE3/3 counterparts (P < 0.01 for the APOE2/2 versus APOE4/4 comparison). After EPA supplementation, n-3 HUFA levels were not significantly different when stratified by APOE genotype, although APOE4 carriers displayed lower plasma 18-HEPE levels than individuals without an APOE4 allele (P = 0.002). CONCLUSIONS: APOE genotype is associated with differential n-3 HUFA and 18-HEPE levels in individuals with multiple colorectal polyps.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eicosapentaenoic AcidDietary SupplementsFatty Acids, Omega-3Apolipoproteins EGenotypeHumansFemaleMaleMiddle AgedAgedColonic PolypsSeafood

Stichwörter der Autor:innen

Apolipoprotein EColorectal polypHighly unsaturated fatty acidOxylipinsingle nucleotide polymorphism

Substanzen

Eicosapentaenoic AcidFatty Acids, Omega-3Apolipoproteins E

Autor:innen und Institutionen

  • Leeds Institute of Medical Research, University of Leeds, UK.
  • Nutrition and Preventive Medicine, Norwich Medical School, University of East Anglia, Norwich, UK; Department of Clinical and Chemical Pathology, Faculty of Medicine, Alexandria University, Egypt.
  • Institute of Cancer Therapeutics, University of Bradford, UK.
  • School of Medicine and Population Health, University of Sheffield, UK.
  • Nutrition and Preventive Medicine, Norwich Medical School, University of East Anglia, Norwich, UK; Norwich Institute of Health Ageing, Norwich, UK.
  • Leeds Institute of Medical Research, University of Leeds, UK. Electronic address: M.A.Hull@leeds.ac.uk.

Förderung

  • Cancer Research UK
  • Medical Research Council
  • National Institute for Health and Care Research
  • Efficacy and Mechanism Evaluation Programme

Zitieren

APA

Sun, G., Davies, J. R., Mell, T., Harland, M., Saleh, R. M. H., Race, A. D., Loadman, P. M., Williams, E. A., Minihane, A. M., & Hull, M. A. (2024). APOE genotype, eicosapentaenoic acid (EPA) supplementation and n-3 highly unsaturated fatty acid (HUFA) levels in patients with multiple colorectal polyps: A secondary analysis of the seAFOod polyp prevention trial. Prostaglandins, Leukotrienes and Essential Fatty Acids. https://doi.org/10.1016/j.plefa.2024.102623

Vancouver

Sun G, Davies JR, Mell T, Harland M, Saleh RMH, Race AD, et al. APOE genotype, eicosapentaenoic acid (EPA) supplementation and n-3 highly unsaturated fatty acid (HUFA) levels in patients with multiple colorectal polyps: A secondary analysis of the seAFOod polyp prevention trial. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2024. doi:10.1016/j.plefa.2024.102623

BibTeX
@article{Sun2024,
  author = {Sun, Ge and Davies, John R and Mell, Tracey and Harland, Mark and Saleh, Rasha M H and Race, Amanda D and Loadman, Paul M and Williams, Elizabeth A and Minihane, Anne Marie and Hull, Mark A},
  title = {APOE genotype, eicosapentaenoic acid (EPA) supplementation and n-3 highly unsaturated fatty acid (HUFA) levels in patients with multiple colorectal polyps: A secondary analysis of the seAFOod polyp prevention trial},
  journal = {Prostaglandins, Leukotrienes and Essential Fatty Acids},
  year = {2024},
  doi = {10.1016/j.plefa.2024.102623}
}
Kostenlos starten →